Hepcinat LP & Hepcinat News

Hepcinat LP and Hepcinat News





US Food and Drug Administration approves Natco Pharma manufacturing facility for Hepcinat LP and Hepcinat

  • FDA has issued a report for the manufacturers of Gilead Sciences licensed Hepcinat LP (ledipasvir 90mg & sofosbuvir 400mg)
  • Report is called Establishment Inspection Report (EIR) from the US Food and Drug Administration authorizing to manufacture generic Harvoni (ledipasvir 90mg & sofosbuvir 400mg) in Telangana, India on January 24th 2017.


Nepal approves Hepcinat LP and Hepciant as hepatitis c treatments


  • Nepal is now authorized to promote Natco Pharma two blockbuster treatments.
  • Hepcinat LP (generic Harvoni) & Hepcinat (sofosbuvir 400mg) or generic Sovaldi.
  • There are exact data that has been compiled on the number of hepatitis C infected individuals in Nepal.
  • Some hepatitis C advocates in Nepal say the number could be in the millions, due to lack of hygiene, education and clean medical equipment.
  • Nepal also has a relative large number of hepatitis C and HIV co-infections, especially in the capital city Kathmandu.

  • Epclusa is velpatasvir 100mg with sofosbuvir 400mg and a generic version of Gilead Sciences approved medicine has been launched, called Velpanat.
  • Natco Pharma received the authorization from Gilead Sciences to market this drug for hepatitis C patients as a pan genotype cure.
  • Natco Pharma states Velpanat treats genotype 1 through 6 with or without cirrhosis.
  • Gilead Sciences has approved the marketing of generic Epclusa, Velpanat in over 101 countries. Mostly low and middle income countries.


hepcinat lp indian government putting brakes on increasing drug prices

  • Indian government has put a stop to rising prices of hepatitis C treatments manufactured in India.
  • Approximately 30 to 60 million are infected with hepatitis C. Hepcinat LP drug cost is approximately $1200.
  • For most developed nations $1200 may not be much. However, for a person from a developing country its definitely out of reach. The average 3rd world nation income is less than $500 a year, that too for a family of 4.
  • Indian government has been pressured from hepatitis C activists to stop the rising prices of all hepatitis c medications, including Hepcinat LP and Hepcinat.


hepcinat-lp-tablets-ledipasvir-90mg sofosbuvir 400mg generic harvoni genotypes 1, 4, 5 or 6

  • Natco Pharma releases the much awaited Hepcinat LP to global marketplace.
  • Hepcinat LP a combination of ledipasvir 90mg and sofosbuvir 400mg treats hepatitis C.
  • Genotypes treated with Hepcinat LP are 1, 4, 5 or 6.
  • Almost 45% of the hepatitis C world population can be treated with Hepcinat LP.
  • Gilead Sciences has authorized with the US Food and Drug Administration to have Natco Pharma manufacture Hepcinat LP.  Hepcinat LP is called Harvoni in the US, UK and EU.  Hepcinat LP is considered the generic version of the mega blockbuster drug Harvoni.
  • Harvoni costs $95,000 for 12 weeks treatment, 84 tablets.  If a hepatitis C patient requires 24 weeks of treatment the cost doubles to $190,000.
  • Hepcinat LP costs only a fraction of the price compared to the US, UK and EU.  Due to the new release of the drug and spiking demand the costs have risen up to $3,000 to $5,000.


sub saharan Africa to receive hepatitis C screening and hepatitis c treatments

  • Soul of Healing – India NGO has exclusive distribution to market and promote hepatitis C treatment in several Sub Saharan African countries.
  • According to African National Congress (ANC) there are strict regulations in disclosing which countries are expected to receive hepatitis C screening and treatment.
  • Due to the success rate of hepatitis C treatments from India, several Sub Saharan African nations have signed agreement to test various metro populations.
  • Soul of Healing – USA had received funding to distribute Hepcinat LP and Hepcinat for those found infected with hepatiis C. The campaign for hepatitis C screening and testing will begin in mid March of 2018. Approximately 10,000 to 50,000 high risk individuals will be targeted for screening.
  • Due to the vast number of populations in Sub Saharan African only a few metro areas will be considered for hepatitis C screening and treatments from Soul of Healing USA and Soul of Healing India NGO.


Hepcinat or generic Sovaldi sofosbuvir 400mg

  • Natco Pharma and Hetero Drugs have inked a deal with Gilead Sciences to mass manufacture Sovaldi (sofosbuvir 400mg) for poorer nations battling hepatitis C.
  • Hepatitis C treatments for decades have not been too effective until sofosbuvir was discovered or synthesized in the Veterans Affairs laboratory in the US.
  • Peg-interferon Alpha and ribavirin were the go to and only choices available for treatment.  Many patients experienced severe side effects, likening to chemotherapy.  Success rate was negligible in most cases.
  • New small molecule sofosbuvir 400mg has been called the wonder drug of hepatitis c treatments.
  • Clinical trials of Hepcinat manufactured by Hepcinat provide great results for those with specific genotypes 1, 2, 3 or 4 accompanied with weight based ribavirin.